NEW YORK, July 24 - Cepheid announced on Tuesday second-quarter revenues of $2 million, compared to $1.2 million from the year ago period. For the six months ended June 30, Cepheid's revenues increased to $5.4 million from $2.1 million.

The maker of equipment for rapidly preparing and analyzing DNA attributed the increase to the extension of sales of its Smart Cycler DNA testing system. During this latest quarter, Cepheid sold the Smart Cycler within North America, Europe, and Asia; in the year ago period, it had access to only the US market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.